Observer experience and accuracy of F-18-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Observer experience and accuracy of F-18-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer. / Zacho, Helle D.; Ravn, Soren; Ejlersen, June A.; Fledelius, Joan; Dolliner, Peter; Nygaard, Sofie T.; Holdgaard, Paw C.; Lauridsen, Jeppe F.; Haarmark, Christian; Hendel, Helle W.; Petersen, Lars J.

In: Nuclear Medicine Communications, Vol. 43, No. 6, 2022, p. 680-686.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Zacho, HD, Ravn, S, Ejlersen, JA, Fledelius, J, Dolliner, P, Nygaard, ST, Holdgaard, PC, Lauridsen, JF, Haarmark, C, Hendel, HW & Petersen, LJ 2022, 'Observer experience and accuracy of F-18-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer', Nuclear Medicine Communications, vol. 43, no. 6, pp. 680-686. https://doi.org/10.1097/MNM.0000000000001550

APA

Zacho, H. D., Ravn, S., Ejlersen, J. A., Fledelius, J., Dolliner, P., Nygaard, S. T., Holdgaard, P. C., Lauridsen, J. F., Haarmark, C., Hendel, H. W., & Petersen, L. J. (2022). Observer experience and accuracy of F-18-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer. Nuclear Medicine Communications, 43(6), 680-686. https://doi.org/10.1097/MNM.0000000000001550

Vancouver

Zacho HD, Ravn S, Ejlersen JA, Fledelius J, Dolliner P, Nygaard ST et al. Observer experience and accuracy of F-18-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer. Nuclear Medicine Communications. 2022;43(6):680-686. https://doi.org/10.1097/MNM.0000000000001550

Author

Zacho, Helle D. ; Ravn, Soren ; Ejlersen, June A. ; Fledelius, Joan ; Dolliner, Peter ; Nygaard, Sofie T. ; Holdgaard, Paw C. ; Lauridsen, Jeppe F. ; Haarmark, Christian ; Hendel, Helle W. ; Petersen, Lars J. / Observer experience and accuracy of F-18-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer. In: Nuclear Medicine Communications. 2022 ; Vol. 43, No. 6. pp. 680-686.

Bibtex

@article{e00a89fcef4b42e5968958dc8b1b695a,
title = "Observer experience and accuracy of F-18-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer",
abstract = "Objective To evaluate the diagnostic accuracy of observers with different levels of experience in reading F-18-sodium fluoride (NaF) PET/CT images for the diagnosis of bone metastases in prostate cancer (PCa) patients. Methods Nine observers with varying NaF PET/CT experience, ranging from no experience to 2000+ examinations, evaluated 211 NaF PET/CT scans from PCa patients participating in one of four prospective trials. Each observer evaluated each NaF PET/CT on a patient level using a trichotomous scale: M0 (no bone metastases), Me (equivocal for bone metastases) and M1 (bone metastases). Subsequently, a dichotomous evaluation was conducted (M0/M1). The final diagnosis was retrieved from the original study. For each observer, ROC curves and the diagnostic accuracy were calculated based on dichotomous and trichotomous scales; in the latter case, Me was first regarded as M1 and then M0. Results Across all experience levels, the sensitivity, specificity and accuracy using the dichotomous scale ranged from 0.81 to 0.89, 0.93 to 1.00 and 0.91 to 0.94, respectively. Employing the trichotomous scale, novice and experienced observers chose Me in up to 20 vs. 10% of cases, respectively. Considering Me as M0, the sensitivity, specificity and accuracy ranged from 0.78 to 0.89, 0.95 to 1.00 and 0.91 to 0.95, respectively. Considering Me as M1, the sensitivity, specificity and accuracy ranged from 0.86 to 0.92, 0.71 to 0.96 and 0.77 to 0.94, respectively. Conclusion Novice observers used the equivocal option more frequently than observers with NaF PET/CT experience. However, on the dichotomous scale, all observers exhibited high and satisfactory accuracy for the detection of bone metastases, making NaF PET/CT an effective imaging modality even in unexperienced hands.",
keywords = "F-18-sodium-fluoride PET, CT, bone metastases, diagnostic accuracy, observer experience, prostate cancer, WHOLE-BODY SPECT/CT, F-18-FLUORIDE PET/CT, INTEROBSERVER AGREEMENT, FLUORIDE PET/CT, F-18-NAF PET/CT, SCINTIGRAPHY, MULTICENTER, GUIDELINES",
author = "Zacho, {Helle D.} and Soren Ravn and Ejlersen, {June A.} and Joan Fledelius and Peter Dolliner and Nygaard, {Sofie T.} and Holdgaard, {Paw C.} and Lauridsen, {Jeppe F.} and Christian Haarmark and Hendel, {Helle W.} and Petersen, {Lars J.}",
year = "2022",
doi = "10.1097/MNM.0000000000001550",
language = "English",
volume = "43",
pages = "680--686",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams & Wilkins",
number = "6",

}

RIS

TY - JOUR

T1 - Observer experience and accuracy of F-18-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer

AU - Zacho, Helle D.

AU - Ravn, Soren

AU - Ejlersen, June A.

AU - Fledelius, Joan

AU - Dolliner, Peter

AU - Nygaard, Sofie T.

AU - Holdgaard, Paw C.

AU - Lauridsen, Jeppe F.

AU - Haarmark, Christian

AU - Hendel, Helle W.

AU - Petersen, Lars J.

PY - 2022

Y1 - 2022

N2 - Objective To evaluate the diagnostic accuracy of observers with different levels of experience in reading F-18-sodium fluoride (NaF) PET/CT images for the diagnosis of bone metastases in prostate cancer (PCa) patients. Methods Nine observers with varying NaF PET/CT experience, ranging from no experience to 2000+ examinations, evaluated 211 NaF PET/CT scans from PCa patients participating in one of four prospective trials. Each observer evaluated each NaF PET/CT on a patient level using a trichotomous scale: M0 (no bone metastases), Me (equivocal for bone metastases) and M1 (bone metastases). Subsequently, a dichotomous evaluation was conducted (M0/M1). The final diagnosis was retrieved from the original study. For each observer, ROC curves and the diagnostic accuracy were calculated based on dichotomous and trichotomous scales; in the latter case, Me was first regarded as M1 and then M0. Results Across all experience levels, the sensitivity, specificity and accuracy using the dichotomous scale ranged from 0.81 to 0.89, 0.93 to 1.00 and 0.91 to 0.94, respectively. Employing the trichotomous scale, novice and experienced observers chose Me in up to 20 vs. 10% of cases, respectively. Considering Me as M0, the sensitivity, specificity and accuracy ranged from 0.78 to 0.89, 0.95 to 1.00 and 0.91 to 0.95, respectively. Considering Me as M1, the sensitivity, specificity and accuracy ranged from 0.86 to 0.92, 0.71 to 0.96 and 0.77 to 0.94, respectively. Conclusion Novice observers used the equivocal option more frequently than observers with NaF PET/CT experience. However, on the dichotomous scale, all observers exhibited high and satisfactory accuracy for the detection of bone metastases, making NaF PET/CT an effective imaging modality even in unexperienced hands.

AB - Objective To evaluate the diagnostic accuracy of observers with different levels of experience in reading F-18-sodium fluoride (NaF) PET/CT images for the diagnosis of bone metastases in prostate cancer (PCa) patients. Methods Nine observers with varying NaF PET/CT experience, ranging from no experience to 2000+ examinations, evaluated 211 NaF PET/CT scans from PCa patients participating in one of four prospective trials. Each observer evaluated each NaF PET/CT on a patient level using a trichotomous scale: M0 (no bone metastases), Me (equivocal for bone metastases) and M1 (bone metastases). Subsequently, a dichotomous evaluation was conducted (M0/M1). The final diagnosis was retrieved from the original study. For each observer, ROC curves and the diagnostic accuracy were calculated based on dichotomous and trichotomous scales; in the latter case, Me was first regarded as M1 and then M0. Results Across all experience levels, the sensitivity, specificity and accuracy using the dichotomous scale ranged from 0.81 to 0.89, 0.93 to 1.00 and 0.91 to 0.94, respectively. Employing the trichotomous scale, novice and experienced observers chose Me in up to 20 vs. 10% of cases, respectively. Considering Me as M0, the sensitivity, specificity and accuracy ranged from 0.78 to 0.89, 0.95 to 1.00 and 0.91 to 0.95, respectively. Considering Me as M1, the sensitivity, specificity and accuracy ranged from 0.86 to 0.92, 0.71 to 0.96 and 0.77 to 0.94, respectively. Conclusion Novice observers used the equivocal option more frequently than observers with NaF PET/CT experience. However, on the dichotomous scale, all observers exhibited high and satisfactory accuracy for the detection of bone metastases, making NaF PET/CT an effective imaging modality even in unexperienced hands.

KW - F-18-sodium-fluoride PET

KW - CT

KW - bone metastases

KW - diagnostic accuracy

KW - observer experience

KW - prostate cancer

KW - WHOLE-BODY SPECT/CT

KW - F-18-FLUORIDE PET/CT

KW - INTEROBSERVER AGREEMENT

KW - FLUORIDE PET/CT

KW - F-18-NAF PET/CT

KW - SCINTIGRAPHY

KW - MULTICENTER

KW - GUIDELINES

U2 - 10.1097/MNM.0000000000001550

DO - 10.1097/MNM.0000000000001550

M3 - Journal article

C2 - 35362691

VL - 43

SP - 680

EP - 686

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 6

ER -

ID: 315266304